{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:20:29Z","timestamp":1789633229402,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008564","name":"Norges Blindeforbund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ophtha.2023.01.009","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T10:56:54Z","timestamp":1674298614000},"page":"509-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Associations between Serial Intravitreal Injections and Dry Eye"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2139-0461","authenticated-orcid":false,"given":"Agni","family":"Malmin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilde M.","family":"Thomseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per T.","family":"F\u00f8rland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2048-225X","authenticated-orcid":false,"given":"Ayyad Z.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne B.","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga-Britt K.","family":"Haugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor P.","family":"Utheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5797-4207","authenticated-orcid":false,"given":"Vegard A.","family":"Forsaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2023.01.009_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ophtha.2017.01.001","article-title":"Trends in vitreoretinal procedures for Medicare beneficiaries, 2000 to 2014","volume":"124","author":"McLaughlin","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.01.009_bib2","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41433-021-01646-3","article-title":"Intravitreal injections: past trends and future projections within a UK tertiary hospital","volume":"36","author":"Chopra","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2023.01.009_bib3","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.01.009_bib4","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","volume":"119","author":"Martin","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.01.009_bib5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/bjophthalmol-2015-307707","article-title":"Incidence and clinical features of post-injection endophthalmitis according to diagnosis","volume":"100","author":"Rayess","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.01.009_bib6","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamaophthalmol.2018.3939","article-title":"Association of acute endophthalmitis with intravitreal injections of corticosteroids or anti-vascular growth factor agents in a nationwide study in France","volume":"136","author":"Baudin","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.01.009_bib7","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.ophtha.2008.05.007","article-title":"Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration","volume":"115","author":"Wickremasinghe","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.01.009_bib8","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/OPX.0000000000001091","article-title":"Effect of povidone iodine 5% on the cornea, vision, and subjective comfort","volume":"94","author":"Ridder","year":"2017","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ophtha.2023.01.009_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12886-020-01615-6","article-title":"Toxicity of povidone-iodine to the ocular surface of rabbits","volume":"20","author":"Kim","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.01.009_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0002-9394(14)76094-5","article-title":"The corneal toxicity of presurgical skin antiseptics","volume":"97","author":"Mac Rae","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.01.009_bib11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ajo.2007.01.028","article-title":"An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration","volume":"143","author":"Fung","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.01.009_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1542-0124(12)70083-6","article-title":"report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2023.01.009_bib13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2023.01.009_bib14","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00417-013-2274-y","article-title":"Minimizing the endophthalmitis rate following intravitreal injections using 0.25 % povidone\u2013iodine irrigation and surgical mask","volume":"251","author":"Shimada","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.01.009_bib15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/cpr.13.50","article-title":"Antiseptics in the era of bacterial resistance: a focus on povidone iodine","volume":"10","author":"Lachapelle","year":"2013","journal-title":"Clin Pract"},{"key":"10.1016\/j.ophtha.2023.01.009_bib16","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1111\/aos.14146","article-title":"Evaluation of signs and symptoms of ocular surface disease after intravitreal injection","volume":"97","author":"Dohlman","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.01.009_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/15569527.2017.1291665","article-title":"Ocular surface effects of repeated application of povidone iodine in patients receiving frequent intravitreal injections","volume":"36","author":"Saedon","year":"2017","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.ophtha.2023.01.009_bib18","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1167\/iovs.07-0588","article-title":"Ocular pathogen or commensal: a PCR-based study of surface bacterial flora in normal and dry eyes","volume":"48","author":"Graham","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2023.01.009_bib19","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2147\/IDR.S162135","article-title":"Pathogens in the Meibomian gland and conjunctival sac: microbiome of normal subjects and patients with Meibomian gland dysfunction","volume":"11","author":"Jiang","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ophtha.2023.01.009_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/129873","article-title":"Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention","volume":"2008","author":"Yoo","year":"2008","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ophtha.2023.01.009_bib21","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.3390\/ijms21093111","article-title":"Dry eye disease and tear cytokine levels-a meta-analysis","volume":"21","author":"Roda","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ophtha.2023.01.009_bib22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2147\/DDDT.S146556","article-title":"Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity","volume":"12","author":"Jiang","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ophtha.2023.01.009_bib23","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1167\/iovs.04-0864","article-title":"Association between symptoms and signs of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study","volume":"46","author":"Lin","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2023.01.009_bib24","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/IAE.0000000000001493","article-title":"Systemic pharmacokinetics and pharmacodynamics of intravitreal aflibercept, bevacizumab, and ranibizumab","volume":"37","author":"Avery","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2023.01.009_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/14628839950516922","article-title":"Treatment of facial vascular lesions with intense pulsed light","volume":"1","author":"Angermeier","year":"1999","journal-title":"J\u00a0Cutan Laser Ther"},{"key":"10.1016\/j.ophtha.2023.01.009_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajo.2017.08.021","article-title":"Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction","volume":"183","author":"Liu","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.01.009_bib27","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","article-title":"The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee","volume":"52","author":"Nelson","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2023.01.009_bib28","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/ICO.0b013e3181d4f366","article-title":"Nonobvious obstructive meibomian gland dysfunction","volume":"29","author":"Blackie","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2023.01.009_bib29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ophtha.2007.06.031","article-title":"Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population","volume":"115","author":"Arita","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.01.009_bib30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/ICL.0000000000000828","article-title":"Effect of repeated topical povidone-iodine and antibiotic applications on meibomian glands and ocular surface parameters in patients with repeated intravitreal injections","volume":"47","author":"Polat","year":"2021","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ophtha.2023.01.009_bib31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/bjo.82.8.971","article-title":"People and eyes: statistical approaches in ophthalmology","volume":"82","author":"Murdoch","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.01.009_bib32","first-page":"84","article-title":"Effects of intravitreal injection on ocular surface and anterior segment parameters","volume":"6","author":"Ulutas","year":"2021","journal-title":"Beyoglu Eye J"},{"key":"10.1016\/j.ophtha.2023.01.009_bib33","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archopht.122.9.1265","article-title":"Relationship between tear volume and tear meniscus curvature","volume":"122","author":"Yokoi","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.01.009_bib34","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1080\/02713683.2018.1514055","article-title":"Tear production levels and dry eye disease severity in a large Norwegian cohort","volume":"43","author":"Yazdani","year":"2018","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2023.01.009_bib35","first-page":"687","article-title":"Key factors in the subjective and objective assessment of conjunctival erythema","volume":"41","author":"Papas","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2023.01.009_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/OPX.0000000000001638","article-title":"Bulbar redness and dry eye disease: comparison of a validated subjective grading scale and an objective automated method","volume":"98","author":"Schulze","year":"2021","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ophtha.2023.01.009_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clae.2012.10.074","article-title":"Comparison of subjective grading and objective assessment in meibography","volume":"36","author":"Pult","year":"2013","journal-title":"Cont Lens Anterior Eye"}],"updated-by":[{"DOI":"10.1016\/j.ophtha.2025.12.024","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000}}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023000453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023000453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:13:24Z","timestamp":1758982404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642023000453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0161642023000453"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.01.009","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between Serial Intravitreal Injections and Dry Eye","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}